According to filings with the U.S. Securities and Exchange Commission, Vertos Medical is raising $45,557,632.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Eric Wichems played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Vertos Medical
Vertos Medical is a medical device company committed to developing innovative, minimally invasive treatments for lumbar spinal stenosis (LSS). Mild, its proprietary technology, is a safe and minimally invasive outpatient procedure that removes a major root cause of lumbar spinal stenosis (LSS) to improve back and leg pain. Mild restores space in the spinal canal through an incision smaller than the size of baby aspirin and that requires no general anesthesia, implants, stitches, steroids or opioids. Performed on over 30,000 patients, clinical data from a one-year Cleveland Clinic study demonstrated that Mild can help many LSS patients stand longer and walk farther with less pain [Mekhail, Nagy, et.al. (2012)]. Mild is cleared by the FDA and nationally covered by Medicare (all ages, all plan types, including Medicare Advantage).

To learn more about Vertos Medical, visit http://www.vertosmed.com/

Contact:
Eric Wichems, Chief Executive Officer
949-349-0008

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.